A carregar...
Optimizing the use of anti-tumor necrosis factor in the management of patients with Crohn’s disease
Since the approval of the first anti-tumor necrosis factor (anti-TNF) therapy in late 1998, the treatment for Crohn’s disease (CD) has been revolutionized. Anti-TNF therapy has been consistently shown in numerous clinical trials to be effective for patients with more aggressive perianal, internal pe...
Na minha lista:
| Publicado no: | Ther Adv Chronic Dis |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4416970/ https://ncbi.nlm.nih.gov/pubmed/25954499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622315579621 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|